Spatial OMICS Market By Product (Instruments, Consumables, and Software), By Technology (Spatial Transcriptomics, Spatial Genomics, and Spatial Proteomics), By Application (Diagnostics, Translation Research, Drug Discovery And Development, Single Cell Analysis, Cell Biology, and Other Applications), By Workflow (Sample Preparation, Instrumental Analysis, and Data Analysis), By End-use (Academic & Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, and Other End-users), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Report Overview

The Spatial OMICS Market size is expected to be worth around USD 1009.6 million by 2033 from USD 364.2 million in 2023, growing at a CAGR of 10.7% during the forecast period 2024 to 2033.

Spatial OMICS refers to a set of technologies that integrate high-throughput molecular profiling with spatial information, allowing the analysis of biological samples within their spatial context. The market’s growth is driven by factors such as the increasing prevalence of genetic diseases, global advancements in sequencing technologies, and greater funding for OMICS research.

Spatial OMICS finds applications in drug research and development, as well as its potential as a tool for cancer diagnosis. For example, in June 2023, Owkin Inc. invested USD 50 million and partnered with NanoString Technologies, Inc., enabling European and American research teams to leverage this technology for cutting-edge cancer research.

Notably, recent technological advancements in spatial proteomics, transcriptomics, and genomics have enhanced our ability to analyze molecular information at a spatial level. One such milestone is Curio Bioscience’s introduction of Curio Seeker, the first high-resolution, whole-transcriptome spatial mapping kit in February 2023, marking the beginning of the company’s commercial activities.

Key Takeaways

• Market Size: Spatial OMICS Market size is expected to be worth around USD 1009.6 million by 2033 from USD 364.2 million in 2023,
• Market Growth: The market growing at a CAGR of 10.7% during the forecast period 2024 to 2033.
• Product Analysis: The product segment is divided into instruments, consumables, and software, with consumables taking the lead in 2023 with a market share of 52.6%.
• Technology Analysis: Considering technology, the market is divided into spatial transcriptomics, spatial genomics, and spatial proteomics. Among these, spatial transcriptomics held a significant share of 44.8%.
• Application Analysis: The diagnostics segment had a tremendous growth rate owing to the rising adoption of spatial OMICS.
• Workflow Analysis: The workflow segment is segregated into sample preparation, instrumental analysis, and data analysis, with the instrumental analysis segment leading the market, holding a revenue share of 40.1%.
• End-Use Analysis: The academic & research institutes segment held a significant share of 47.8%.
• Regional Analysis: North America led the market by securing a market share of 48.2% in 2023.

Product Analysis

The consumables segment led in 2023, claiming a market share of 52.6% as these tools enable researchers to accurately analyze the spatial distribution of biomolecules within tissues or cells. The demand for consumables is driven by the growing adoption of spatial OMICS technologies in areas such as neuroscience, cancer research, and developmental biology.

Additionally, advancements in spatial OMICS techniques and the development of new assays contribute to the growth of the consumables segment in the market.

Technology Analysis

Spatial transcriptomics held a significant share of 44.8% due to its ability to provide a complete understanding of the spatial arrangement of tissue’s gene expression. There has been a significant rise in the applications of spatial transcriptomics in cancer research, developmental biology, neuroscience, and immunology aids, which further aids the growth of this segment.

Moreover, the technological advancements in spatial transcriptomics such as improved resolution, sensitivity, and scalability are further fueling this segment’s expansion.

Application Analysis

The diagnostics segment had a tremendous growth rate owing to the rising adoption of spatial OMICS in clinical and research applications, particularly in neurology and oncology, where spatially fixed molecular information is essential in order to understand disease mechanisms, identify biomarkers, and develop targeted therapies.

Additionally, the advancements in spatial OMICS platforms, such as multiplexing capabilities, improved imaging resolution, and data analysis tools, are further boosting the segment’s growth. With the rising demand for multiplexed and spatially fixed molecular analysis, this segment is expected to experience substantial propulsion in the years to come.

Workflow Analysis

The instrumental analysis segment grew at a substantial rate, generating a revenue portion of 40.1% due to cutting-edge advancements in technologies such as microscopy and mass spectroscopy. These innovations enable high-resolution, high-speed, and high-throughput analysis of proteins and nucleic acids, driving applications in drug development, biomarker discovery, and diagnostics.

As technological advancements continue, the instrumental analysis segment is poised to play a vital role in the market’s growth trajectory. This segment’s development is expected to unlock new possibilities in spatial OMICS research and applications.

By End-use Analysis

The academic & research institutes segment held a significant share of 47.8% and is expected to have substantial growth during the forecast period. The adoption of spatial OMICS in translating real-time tissue responses to external agents drives its use in academic and translational research.

Genomic studies within these institutions allow researchers and healthcare practitioners to analyze human tissue and cell behavior across different individuals and environments. This is likely to provide profitable projections for the segment’s growth, even in the coming future.

Key Market Segments

By Product

• Instruments
• Consumables
• Software

By Technology

• Spatial Transcriptomics
• Spatial Genomics
• Spatial Proteomics

By Application

• Diagnostics
• Translation Research
• Drug Discovery And Development
• Single Cell Analysis
• Cell Biology
• Other Applications

By Workflow

• Sample Preparation
• Instrumental Analysis
• Data Analysis

By End-use

• Academic & Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Other End-users

Drivers

Growing Prevalence of Cancer

The growing prevalence of cancer worldwide is driving the spatial OMICS market by increasing the demand for advanced diagnostic and therapeutic techniques. Spatial economics enables researchers to analyze the spatial distribution of molecules within the tissues, providing valuable insights into cancer biology and tumor heterogeneity. This information is being used to develop highly effective personalized cancer treatments and diagnostics. With the surge in number of cancer cases across the globe, the market is likely to have significant propulsion in the coming years.

According to data provided in January 2023 by the Spanish Network of Cancer Registries (REDECAN), around 279,260 new cases of cancer were anticipated to occur in Spain by 2023. Among these, there were projected to be 31,282 cases of lung cancer, 42,721 cases of colorectal cancer, and 21,694 cases of urinary bladder cancer. The growing burden of cancer, coupled with the rising demand for precision medicine approaches, especially for cancer, genetic diseases, and rare diseases, creates lucrative prospects for the market.

Restraints

High Cost of Specialized Instruments and Equipment

The high costs associated with spatial OMICS techniques stem from several factors. Firstly, specialized instruments and equipment required for these techniques contribute significantly to the overall cost. Additionally, consumables such as reagents and assay kits are essential but can be expensive. Secondly, investing in trained personnel adds to the financial burden.

Lastly, the upfront costs of purchasing and maintaining sophisticated technologies, along with ongoing expenses for consumables and data analysis software, limit the accessibility of spatial OMICS. These financial challenges may impede the market’s growth.

Opportunities

Technological Advancements in Spatial OMICS

The application of machine learning and computational tools further enhances spatial OMICS capabilities and diversifies its applications. This is expected to create lucrative opportunities for the market. For example, multiplexed imaging techniques enable simultaneous detection of multiple biomolecules, providing a comprehensive view of complex molecular interactions within tissues.

Additionally, innovations in sample preparation, including tissue-clearing methods, enhance clinical relevance. These technological strides position spatial OMICS to play an increasingly pivotal role across diverse scientific disciplines, driving exponential market development. According to a Spatial Omics conference held by VIB conferences, the spatial OMICS has accelerated research in various traditionally challenging study areas, including cancer. Numerous researchers are beginning to focus on the instant clinical applications of spatial OMICS.

In February 2023, Curio Bioscience introduced the Curio Seeker, which utilizes Slide-seq v2 technology. This innovative system enables large-scale whole transcriptome spatial tissue mapping at single-cell resolution. Notably, the in situ barcoding approach doesn’t necessitate any specific hardware; it simply requires mounting the tissue on the Curio Seeker Tile.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic and geopolitical factors exert a significant influence on the Spatial OMICS market, shaping its growth trajectory and dynamics. Macroeconomic factors such as increased healthcare expenditures and government funding, positively impact the market by driving investment in research and development.

Geopolitical factors such as trade tensions and economic sanctions can disrupt supply chains and hinder market growth. However, strategic collaborations and partnerships among countries can foster innovation and expand market opportunities.

Latest Trends

Growing Popularity of Personalized Medicines

The growing demand for personalized medicine in recent years is expected to create lucrative prospects for the market due to the high demand for precise and targeted therapies. Spatial OMICS enables researchers to analyze individual cells and tissues, providing valuable insights into disease mechanisms and treatment responses. This information can be used to develop personalized treatment plans tailored to individual patient’s needs. The rising adoption of precision medicine approaches, such as targeted therapies and immunotherapies, is fueling the growth of the market.

Consequently, a large number of pharmaceutical companies and research institutes are collaborating for the development of advanced precision medicines. In June 2022, the Wexner Medical Center of Ohio State University (OSU) and Siemens Healthineers collaborated to advance personalized medicine and increase access to cost-effective and high-quality healthcare via the use of hi-tech imaging & treatment technologies at the patient care and research centers of OSU.

Regional Analysis

North America is leading the Spatial OMICS Market

North America stands out as the most significant global spatial OMICS market, holding a major share of market revenue in 2022. The region’s robust research infrastructure, substantial funding, and access to cutting-edge technology drive its growth. Well-established research institutions and universities foster innovation, and collaborations between academia and industry promote advanced spatial omics technologies. The strong scientific research community encourages breakthroughs and innovation.

In 2023, the Keck School of Medicine at the University of Southern California (USC) secured a 5-year, US$ 50.3 million research grant from the National Institutes of Health (NIH). This substantial funding will support a multi-omics study conducted by a consortium of six sites. The study aims to investigate various health conditions, including fatty liver disease, hepatocellular carcinoma, chronic kidney disease, and asthma.

The Asia Pacific region is expected to experience the highest growth during the forecast period

The Asia Pacific market is expected to exhibit the fastest growth during the forecast period. This growth is primarily driven by increased incidences of cancer, diabetes, Alzheimer’s disease, rheumatoid arthritis, and other neurodegenerative, autoimmune, and metabolic disorders.

According to The Cancer Atlas, southern, eastern, and southeastern Asia contribute to 44% of global cancer cases and 51% of cancer deaths. China leads in cancer burden, followed by Japan, India, Indonesia, and Korea. Notably, Japan’s technological advancement and high adoption of genomics and transcriptomics-based techniques significantly contribute to market growth.

Key Regions and Countries

North America

• US
• Canada

Europe

• Germany
• France
• The UK
• Spain
• Italy
• Russia
• Netherland
• Rest of Europe

Asia Pacific

• China
• Japan
• South Korea
• India
• Australia
• New Zealand
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Rest of MEA

Key Players Analysis

The major players in the Spatial OMICS market are actively engaged in the development and introduction of innovative products, as well as implementing strategic initiatives aimed at enhancing their competitive positioning. For instance, in September 2023, Multiomics CRO Psomagen introduced Spatial Biology services for 10X Genomics Xenium.

This platform revolutionizes spatial biology, allowing researchers worldwide to analyze the interplay of genes and proteins within their native tissue context. It represents a pivotal moment in the scientific community’s access to spatial genomics.

Recent Developments

• In March 2024, 10x Genomics launched commercial distribution of the eagerly anticipated Visium HD Spatial Gene Expression instrument. This cutting-edge tool empowers researchers to thoroughly analyze FFPE tissue samples by quantifying spatial gene expression across the entire transcriptome at a single-cell resolution.
• In November 2023, OWKIN and 10x Genomics, Inc. joined forces to incorporate 10x Genomics’ single-cell and spatial omics technologies into the ambitious MOSAIC project. MOSAIC has gained recognition for its groundbreaking work in tumor analysis for therapeutic discovery. This US$50 million initiative utilizes single-cell resolution mapping of tumor structures through spatial omics technology.

Top Key Players

• 10x Genomics
• Akoya Biosciences, Inc.
• Bio-Techne Corporation
• BioSpyder, Inc.
• Bruker Corporation
• Danaher Corporation
• Diagenode Diagnostics (Hologic, Inc.)
• Ionpath, Inc.
• Millennium Science Pty Ltd.
• NanoString Technologies, Inc.
• PerkinElmer, Inc.
• S2 Genomics, Inc.
• Other Key Players

 Report Scope